The Elden Ring Nightreign network test is starting soon, and if you didn’t get accepted to From’s new roguelike, you can buy your way in.

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, Ratings ...

This article explores the transformative potential and challenges of single cell omics in advancing our understanding of ...